ZITUVIMET XR 50-500 MG TABLET

What it is

ZITUVIMET XR 50-500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as sitagliptin and metformin hydrochloride, under the trade name “ZITUVIMET XR”.

FDA gives its dosage form as tablet, film coated, extended release and its route as oral.

The labeler, the company named on the label, is Zydus Pharmaceuticals USA Inc.

FDA lists it under 2 Established Pharmacologic Classes: Biguanide and Dipeptidyl Peptidase 4 Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70710-1804-06.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $150.29 for 30 tablets (30 × $5.00957 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-05-20. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-05-20. The file is new; the price is not.

What NADAC measures · Why 30 tablets · NADAC explanation codes · Carried-forward prices

The NDC

• 70710-1804-06 · Zydus Pharmaceuticals USA Inc. · $5.00957 per EA · eff. 2026-05-20 filed carried forward

Other strengths, forms and brands

11 other products in the NADAC file share the FDA nonproprietary name sitagliptin and metformin hydrochloride with ZITUVIMET XR 50-500 MG TABLET.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-08-05, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $5.00957 per EA filed.

Of the 71 other products in FDA’s Biguanide class priced per EA, 46 have a higher middle NADAC price and 25 a lower one. The one in the middle is SYNJARDY XR 5-1,000 MG TABLET, at $5.61111 per EA filed (eff. 2026-09-23).

Of the 43 other products in FDA’s Dipeptidyl Peptidase 4 Inhibitor class priced per EA, 30 have a higher middle NADAC price and 13 a lower one. The one in the middle is TRIJARDY XR 12.5-2.5-1,000 MG, at $5.62766 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.